ArticleLeukemia2014
Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.
Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- CALR frameshift mutation detection in myeloproliferative neoplasms by microfluidic chip analysis.Laboratory medicine · 2025Article
- Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?Frontiers in medicine · 2023Review
- The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.International journal of molecular sciences · 2021Review
- Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients.Advances in hematology · 2020Article
- Detection ofMediterranean journal of hematology and infectious diseases · 2019Article
- Selected Parameters of Angiogenesis and the JAK2, CALR, and MPL Mutations in Patients With Essential Thrombocythemia.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018Article
- EAGLE: Explicit Alternative Genome Likelihood Evaluator.BMC medical genomics · 2018Article
- Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.Oncotarget · 2016Article
- Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study.Chinese medical journal · 2016Article
- Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis.Annals of laboratory medicine · 2016Article
- Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016Article
- Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.Bone marrow transplantation · 2015Article
- Article
- Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.Blood cancer journal · 2015Article
- JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms.Haematologica · 2015Article
- Clinical relevance between CALR mutation and myeloproliferative neoplasms.Stem cell investigation · 2015Review
- Article
- Calreticulin mutations in myeloproliferative neoplasms.Rambam Maimonides medical journal · 2014Article
- An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.Leukemia · 2014Review
- Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.Haematologica · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.